Table 2.
Case ID | Gestational week | Primary indication# | Detailed clinical indication(s)*: | Low-Pass GS |
---|---|---|---|---|
16BA0152 | 16 | DSS | High risk Down syndrome screen, and family history of thalassemia | seq[GRCh37] del(16)(p13.3) chr16:g.216271_235599del |
16BA0064 | 28 | AUS | Multiple congenital abnormalities, cardiomegaly, thickened myometrium, pericardial effusion, tricuspid regurgitation, abdominal and thoracic effusion | seq[GRCh37] del(16)(p13.3) chr16:g.216050_235599del |
18BA0454 | 17 | FHX | Family history of thalassemia | seq[GRCh37] del(16)(p13.3) chr16:g.216290_235599del |
18BA0351 | 17 | AMA | Previous pregnancy with chromosomal abnormality, advanced maternal age, and family history of thalassemia and cleft lip and palate in mother | seq[GRCh37] del(16)(p13.3) chr16:g.216050_229978del |
18BA0145 | 18 | FHX | Previous miscarriage and family history of thalassemia | seq[GRCh37] del(16)(p13.3) chr16:g.217556_231140del |
18BA0425 | 17 | FHX | Family history of thalassemia | seq[GRCh37] del(16)(p13.3) chr16:g.217215_231140del |
18BA0218 | 21+6 | FHX | Family history of thalassemia | seq[GRCh37] del(16)(p13.3) chr16:g.217215_231140del |
17BA0605 | 23+4 | AUS | Nuchal edema, echogenic bowel, pericardial effusion, oligohydramnios | seq[GRCh37] del(16)(p13.3) chr16:g.216530_235599del |
18BA0115 | 26 | AUS | Borderline risk for Down syndrome screen, structural abnormality | seq[GRCh37] del(16)(p13.3) chr16:g.216236_235599del |
18BA0376 | 23 | AUS | Cardiac structural abnormality | seq[GRCh37] del(16)(p13.3) chr16:g.217392_231140del |
18BA0453 | 17 | FHX | Family history of thalassemia | seq[GRCh37] del(16)(p13.3) chr16:g.216050_235599del |
18BA0442 | 16 | FHX | Family history of thalassemia | seq[GRCh37] del(16)(p13.3) chr16:g.217349_231140del |
19C0339-W | 21+4 | AUS | Cardiomegaly, pericardial effusion, thickened myometrium, enlarged liver | seq[GRCh37] del(16)(p13.3) chr16:g.216149_235599del |
19C0855-W | 11+5 | AUS | NT 4.75-mm, increased placental thickness, absent nasal bone | seq[GRCh37] del(16)(p13.3) chr16:g.216149_235599del |
17C1244-A | 13+5 | DSS | Fetal anomalies: NT 3.3-mm, positive Down syndrome screen: Risk: 1:6, T18 & T13 positive | seq[GRCh37] del(5)(q23.3)mat chr5:g.127783782_128082258del |
18BA0221 | 17+2 | AUS | NT 3.5-mm | seq[GRCh37] del(X)(p21.1)mat chrX:g.32311051_32342286del |
19C1149-W | 12 | AUS | NT 5.22-mm, high risk Down syndrome screen | seq[GRCh37] dup(8)(p21.2q24.3)dn chr8:g.23814437_146298884mos dup[0.3] |
NT, nuchal translucency, -SEA, α0-thalassemia of southeast Asian deletion.
AUS: Abnormal Ultrasound; DSS: 1st/2nd trimester aneuploidy screening high risk; AMA: Advanced Maternal Age; FHX: Family history.